ANXA2 and acute myeloblastic leukemia with maturation: In this study, the serum concentration of ANXA2 in AM patients was determined by ELISA for the first time, which was significantly higher than that in hysteromyoma patients (P < 0.05), suggesting that ANXA2 might be a new marker for the diagnosis of AM.